Ongoing Research Protocols
JNMC Women’s and Children’s Health Research Unit, KLE University’s J N Medical College, Belgaum
- “Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial” funded by the Global Network for Women’s and Children’s Health Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA (May 2019 to April 2022)
- “Performance, Safety and Efficacy of a New Cryotherapy Device for Cervical Dysplasia in Low and Middle Income Countries” project in collaboration with Johns Hopkins Medical Institutions, Karnataka Institute of Medical Sciences, Hubballi and The Karnatak Cancer Therapy and Research Institute and funded by National Institute of Health/National Cancer Institute (NIH/NCI), USA (May 2019 to April 2021)
- “Low-birthweight Infant Feeding Exploration (LIFE)” project in collaboration with Ariadne Labs/Harvard T.H. Chan School of Public Health, Boston, MA and funded by Bill & Melinda Gates Foundation (November 2018 to October 2020)
- “CRADLE-4: Can Reduction of Adverse pregnancy outcomes occur with planned DeLivery vs. Expectant management in pre-eclampsia?” in collaboration with King’s College, London co-funded by UK Medical Research Council and Department of Biotechnology, Govt. of India (October 2018 to September 2021)
- “Prevalence and outcomes of abnormal continuous wave Doppler flow indices in unselected obstetric populations in low- and middle income countries: The Umbiflow™ International Study (A65924)” Sponsored by World Health Organization, Geneva. (August 2018 to July 2019)
- “Study of Cause of Death among Preterm Birth: Asia” in collaboration with RTI International, USA and J J M Medical College Davangere with funding from Bill & Melinda Gates Foundation, USA (November 2017 – October 2020)
- “Breastfeeding Education Support Tool for Baby (BEST4Baby)” funded by Fogarty International Center, National Institutes of Health, USA (October 2017 – September 2020)
- “The WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns) Trials:”
a. WHO ACTION-I TRIAL – A65913: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomes.
b. WHO ACTION-II TRIAL – A65916: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes.
Sponsored by World Health Organization, Geneva from June 2017 to May 2019
- “Maternal and Newborn Health Registry (MNH Registry)”, funded by the Global Network for Women’s and Children’s Health Research of the National Institute of Child Health and Human Development, USA
(January 2008 – April 2023)